1. Pharmacologic Management of Bladder Dysfunction in Adult Women
- Author
-
Katherine K. O'Dell
- Subjects
Adult ,medicine.medical_specialty ,Botulinum Toxins ,Bladder Pain Syndrome ,Urinary Incontinence, Stress ,Pharmacological management ,Cystitis, Interstitial ,Urology ,Administration, Oral ,Urinary incontinence ,Administration, Cutaneous ,Critical Care Nursing ,Risk Assessment ,Severity of Illness Index ,Pediatrics ,Quality of life ,Lower urinary tract symptoms ,Maternity and Midwifery ,medicine ,Nursing Interventions Classification ,Humans ,Behavior management ,Intensive care medicine ,Aged ,Urinary Bladder, Overactive ,business.industry ,Urinary Bladder Diseases ,Estrogens ,Middle Aged ,Prognosis ,Urination Disorders ,medicine.disease ,Thiazoles ,Urodynamics ,Treatment Outcome ,Urinary Incontinence ,Overactive bladder ,Mandelic Acids ,Urological Agents ,Acetanilides ,Female ,medicine.symptom ,business - Abstract
Women commonly experience lower urinary tract symptoms that can severely decrease quality of life. Symptoms are often associated with diagnoses such as urinary incontinence, overactive bladder, and bladder pain syndrome. Expanding evidence supports the effectiveness of many basic nursing interventions, including behavioral management education and optimal use of various pharmacologic agents. The primary focus of this article is pharmacologic treatment of urinary symptoms in women, including new and emerging agents.
- Published
- 2014
- Full Text
- View/download PDF